Regulatory Reform and "Blue Hat" Modernization
The State Administration for Market Regulation (SAMR) has modernized the "Blue Hat" (health food registration) process in 2026 to allow for faster market entry of innovative products.
Foreign brands are benefitting from clearer pathways for "novel ingredients," particularly those aligned with Traditional Chinese Medicine (TCM). However, 2026 oversight remains strict on marketing claims. Brands must ensure that Chinese-language descriptions align exactly with registered efficacy—claims of "curing" myopia or cataracts are strictly prohibited and result in immediate delisting from e-commerce platforms.
3 Views